 Altamira Therapeutics Ltd NASDAQ: CYTO shares are surging after announcing preclinical efficacy data from testing its Bentrio nasal spray against the omicron variant of the SARS-CoV-2 virus. Bentrio is a drug-free nasal spray for protection against airborne viruses and allergens. 